Niagen Bioscience Announces a Newly Published Analysis of Past Clinical Studies Demonstrating Niagen® (Patented Nicotinamide Riboside, NR) Supplementation Improved a Muscle-Specific Marker of Biologi

Go back to Niagen Bioscience Announces a Newly Published Analysis of Past Clinical Studies Demonstrating Niagen® (Patented Nicotinamide Riboside, NR) Supplementation Improved a Muscle-Specific Marker of Biologi
(NASDAQ: NAGE) Delayed: 3.02 +0.03 (1.00%)
Previous Close $2.99    52 Week High
Open $2.99    52 Week Low
Day High $3.02    P/E N/A 
Day Low $2.97    EPS
Volume 184,947